Balcom Alexandra 4

What Happened

• Alexandra Balcom, Chief Financial Officer of Nuvalent (NUVL), exercised 11,430 stock options on June 1, 2026 at $6.89 per share (cost = $78,753) and sold the resulting 11,430 shares in multiple open-market transactions the same day.
• The sales were executed in several blocks at prices ranging roughly from $94.48 to $104.19 (weighted average prices reported per block), generating total gross proceeds of about $1,128,079. After paying the exercise cost (~$78.8k), the transaction yielded roughly $1.05M before taxes, fees and other withholdings.
• These are sales (routine monetization) rather than a purchase — the shares were acquired by option exercise and then sold.

Key Details

• Transaction date: 2026-06-01; Form 4 filed 2026-06-03 (timely filing).
• Exercise: 11,430 shares acquired at $6.89 each (total $78,753).
• Open-market sales: 11,430 shares sold in multiple trades at weighted-average prices per block, total proceeds ~ $1,128,079. Price ranges for the blocks: $94.48–95.40; $95.51–96.45; $97.00–97.98; $98.10–99.08; $99.33–100.32; $100.33–101.29; $101.44–102.37; $103.49–104.19 (see filing footnotes).
• Footnotes: Trades were effected under a Rule 10b5-1 trading plan adopted December 23, 2025 (planned trades). The option shares were fully vested.
• Shares owned after the transactions are not specified in the material provided in this summary.

Context

• This is effectively an option exercise followed by immediate sales (a common way for insiders to monetize vested options). Because the sales were executed under a pre-established 10b5-1 plan, they were pre-scheduled rather than ad hoc trades.
• Calculation note: the approximate net cash amount quoted (~$1.05M) is gross proceeds minus exercise cost and does not account for taxes, broker fees, or other withholdings.